BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Authors » John Fox

Articles by John Fox

Preeclampsia outcomes improved in mouse models

May 24, 2017
By John Fox
A new Japanese study’s findings cast light on the role of intracellular signaling mediated by reactive oxygen species (ROS) in maintaining placental angiogenesis, which may explain the failure of clinical trials of antioxidants in preeclampsia and supports their use for the currently untreatable condition.
Read More

Preeclampsia outcomes improved in mouse models

May 19, 2017
By John Fox
A new Japanese study's findings cast light on the role of intracellular signaling mediated by reactive oxygen species (ROS) in maintaining placental angiogenesis, which may explain the failure of clinical trials of antioxidants in preeclampsia and supports their use for the currently untreatable condition.
Read More

First antibody directly targeting Ras oncogenes is now developed

May 17, 2017
By John Fox
The first therapeutic monoclonal antibody (MAb) that selectively targets activated intracellular cytosolic Ras mutant proteins, which are inaccessible to current antibodies, has been developed and assessed preclinically in a new South Korean study.
Read More

First antibody directly targeting Ras oncogenes is now developed

May 16, 2017
By John Fox
The first therapeutic monoclonal antibody (MAb) that selectively targets activated intracellular cytosolic Ras mutant proteins, which are inaccessible to current antibodies, has been developed and assessed preclinically in a new South Korean study.
Read More

Study suggests new approach to fighting infections

May 15, 2017
By John Fox
An international study led by researchers at Monash University's Biomedicine Discovery Institute (BDI) in Melbourne has shown how the hepatitis C virus (HCV) takes over the communication systems in infected host cells, revealing potential new therapeutic targets for HCV and other diseases.
Read More

First lymphatic brain scavenger cells discovered

May 10, 2017
By John Fox

Australian scientists at the University of Queensland (UQ) have discovered a new type of lymphatic brain "scavenger" cell in zebrafish, which may provide protection from stroke and dementias such as Alzheimer's disease and have important implications for drug development.


Read More

First lymphatic brain scavenger cells discovered

May 9, 2017
By John Fox
Australian scientists at the University of Queensland (UQ) have discovered a new type of lymphatic brain "scavenger" cell in zebrafish, which may provide protection from stroke and dementias such as Alzheimer's disease and have important implications for drug development.
Read More

Molecular structure may hold key to neurodegenerative diseases

May 3, 2017
By John Fox
HONG KONG – Japanese researchers have determined for the first time the detailed atomic structure of a key molecule involved in intracellular transmission, which should contribute to development of better therapeutic approaches for neurodegenerative diseases such as Alzheimer's.
Read More

Antibody study may change TB vaccine design

May 3, 2017
By John Fox
The findings of a Chinese study showing that some health care workers exposed to high doses of the TB pathogen Mycobacterium tuberculosis (Mtb) made protective antibodies against future infection, despite having had no previous latent TB infection, may have important implications for rational development of new therapeutic and protective vaccines.
Read More

Antibody study may change TB vaccine design

May 2, 2017
By John Fox
The findings of a Chinese study showing that some health care workers exposed to high doses of the TB pathogen Mycobacterium tuberculosis (Mtb) made protective antibodies against future infection, despite having had no previous latent TB infection, may have important implications for rational development of new therapeutic and protective vaccines.
Read More
Previous 1 2 … 35 36 37 38 39 40 41 42 43 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing